Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 PK Interaction Study of Valemetostat With Rifampicin in Healthy Japanese Subjects
jRCT2080225242Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of valemetostat in cancer, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Pharmacokinetics of valemetostat (DS-3201a) with and without rifampicin. Started Jun 2020; status: completed.
02
Drugs
valemetostat
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080225242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225242.